A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
Background: Cuproptosis is a newly discovered non-apoptotic form of cell death that may be related to the development of tumors. Nonetheless, the potential role of cuproptosis-related lncRNAs in tumor immunity formation and patient-tailored treatment optimization of lung adenocarcinoma (LUAD) is sti...
Main Authors: | Chao Ma, Feng Li, Zhuoyu Gu, Yang Yang, Yu Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1146840/full |
Similar Items
-
Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
by: Chao Ma, et al.
Published: (2023-02-01) -
Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
by: Hui Chen, et al.
Published: (2023-01-01) -
Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01) -
Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01) -
Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
by: Binfeng Liu, et al.
Published: (2022-12-01)